Regulatory links between PLC enzymes and Ras superfamily GTPases: Signalling via PLCε

Advances in Enzyme Regulation

Volumn 49, Issue 1, 2009, Pages 54-58

  Bunney, Tom D ^a   Baxendale, Rhona W ^a   Katan, Matilda ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISOENZYME; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE PHOSPHODIESTERASE; PHOSPHOLIPASE C; PHOSPHOLIPASE C EPSILON; RAC PROTEIN; RAS PROTEIN;

ANIMAL; ARTICLE; ENZYME ACTIVATION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ENZYME ACTIVATION; HUMANS; ISOENZYMES; PHOSPHOINOSITIDE PHOSPHOLIPASE C; RAC GTP-BINDING PROTEINS; RAS PROTEINS; SIGNAL TRANSDUCTION; TYPE C PHOSPHOLIPASES;

EID: 66449113464     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.advenzreg.2009.01.004     Document Type: Article

References (24)

1. Bai Y., Edamats H., Maeda S., Saito H., Suzuki N., Satoh T., and Kataoka T. Crucial role of phospholipase Cepsilon in chemical carcinogen-induced skin tumor development. Cancer Res 64 (2004) 8808-8810
2. Brown M.D., and Sacks D.B. IQGAP1 in cellular signaling: bridging the GAP. Trends Cell Biol 16 (2006) 242-249
3. Bunney T.D., Harris R., Gandarillas N.L., Josephs M.B., Roe S.M., Sorli S.C., et al. Structural and mechanistic insights into ras association domains of phospholipase C epsilon. Mol Cell 21 (2006) 495-507
4. Bunney T.D., and Katan M. Phospholipase C epsilon: linking second messengers and small GTPases. Trends Cell Biol 16 (2006) 640-648
5. Campbell P.M., Singh A., Williams F.J., Frantz K., Ulfu A.S., Kelley G.G., and Der C.J. Genetic and pharmacologic dissection of Ras effector utilization in oncogenesis. Methods Enzymol 407 (2006) 195-217
6. Downward J. Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 3 (2003) 11-22
7. Dvorsky R., and Ahmadian M.R. Always look on the bright site of Rho: structural implications for a conserved intermolecular interface. EMBO Rep 5 (2004) 1130-1136
8. Harden T.K., and Sondek J. Regulation of phospholipase C isozymes by Ras superfamily GTPases. Annu Rev Pharmacol Toxicol 46 (2006) 355-379
9. Harris R., Bunney T.D., Katan M., and Driscoll P.C. Backbone 1H, 13C, and 15N resonance assignments for the two 13 kD Ras associating domains (RA1 and RA2) from phospholipase C epsilon. J Biomol NMR 33 (2005) 138
10. Herrmann C. Ras-effector interactions: after one decade. Curr Opin Struct Biol 13 (2003) 122-129
11. Hinkes B., Wiggins R.C., Gbadegesin R., Vlangos C., Seelow D., Nurnberg G., et al. Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat Genet 38 (2006) 1397-1405
12. Ikuta S., Edamatsu H., Li M., Hu L., and Kataoka T. Crucial role of phospholipase C epsilon in skin inflammation induced by tumor-promoting phorbol ester. Cancer Res 68 (2008) 64-72
13. Jezyk M.R., Snyder J.T., Gershberg S., Worthylake D.K., Harden T.K., and Sondek J. Crystal structure of Rac1 bound to its effector phospholipase C-β2. Nat Struct Mol Biol 13 (2006) 1135-1140
14. Kiel C., and Serrano L. Prediction of Ras-effector interactions using position energy matrices. Bioinformatics 23 (2007) 2226-2230
15. Kiel C., Wohlgemuth S., Rousseau F., Schymkowitz J., Ferkinghoff-Borg J., Wittinghofer F., et al. Recognizing and defining true Ras binding domains II: in silico prediction based on homology modelling and energy calculations. J Mol Biol 348 (2005) 759-775
16. Lamuño Gandarillas N., Bunney T.D., Josephs M.B., Gierschik P., Katan M., et al. In vitro reconstitution of activation of PLCε by Ras and Rho GTPases. Methods Mol. Biol 462 (2009) 379-389
17. Pacold M.E., Suire S., Perisic O., Lara-Gonzalez S., Davis C.T., Walker E.H., et al. Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma. Cell 103 (2000) 931-943
18. 2 by Rac GTPases. J Biol Chem 280 (2005) 38923-38931
19. Sorli S.C., Bunney T.D., Sugden P.H., Paterson H.F., and Katan M. Signaling properties and expression in normal and tumor tissues of two phospholipase C epsilon splice variants. Oncogene 24 (2005) 90-100
20. Stieglitz B., Bee C., Schwarz D., Yildiz O., Moshnikova A., Khokhlatchev A., et al. Novel type of Ras effector interaction established between tumour suppressor NORE1A and Ras switch II. Embo J 27 (2008) 1995-2005
21. Suh P.G., Park J.I., Manzoli L., Cocco L., Peak J.C., Katan M., et al. Multiple roles of phosphoinositide-specific phospholipase C isozymes. BMB Rep 41 (2008) 415-434
22. Suire S., Hawkins P., and Stevens L. Activation of phosphoinositide 3-kinase gamma by Ras. Curr Biol 12 (2002) 1068-1075
23. Walliser C., Retlich M., Harris R., Everett K.L., Josephs M.B., Vatter P., et al. Rac regulates its effector phospholipase C gamma 2 through interaction with a split PH domain. J Biol Chem 283 (Aug 2008) 30351-30362
24. Wohlgemuth S., Kiel C., Kramer A., Serrano L., Wittinghofer F., and Herrmann C. Recognizing and defining true Ras binding domains I: biochemical analysis. J Mol Biol 348 (2005) 741-758